Cargando…

Risky Sexual Behavior Among Individuals Receiving Buprenorphine/Naloxone Opiate Dependency Treatment: HIV Prevention Trials Network (HPTN) 058

INTRODUCTION: Understanding the role of opiate dependency treatment in risky sexual behavior could help optimize interventions for people who inject drugs (PWID). OBJECTIVES: We evaluated whether long-term medication-assisted treatment (LT-MAT) of opiate dependency with buprenorphine/naloxone influe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shava, Emily, Lipira, Lauren E., Beauchamp, Geetha G., Donnell, Deborah J., Lockman, Shahin, Ruan, Yuhua, Shao, Yiming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JAIDS Journal of Acquired Immune Deficiency Syndromes 2018
Materias:	Prevention Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5997518/ https://www.ncbi.nlm.nih.gov/pubmed/29557855 http://dx.doi.org/10.1097/QAI.0000000000001683

Ejemplares similares

Brief Report: Durability of the Effect of Financial Incentives on HIV Viral Load Suppression and Continuity in Care: HPTN 065 Study
por: El-Sadr, Wafaa M., et al.
Publicado: (2019)

Sociodemographic and clinical characteristics of patients with long-term remission with buprenorphine / naloxone in opiate use disorder
por: Kahya, Y., et al.
Publicado: (2021)

Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men
por: Ziaaddini, Hassan, et al.
Publicado: (2018)

Neuropsychological function is improved among opioid dependent adults who adhere to opiate agonist treatment with buprenorphine-naloxone: a preliminary study
por: Scott, Travis M., et al.
Publicado: (2017)

Reconsidering the Usefulness of Adding Naloxone to Buprenorphine
por: Blazes, Christopher K., et al.
Publicado: (2020)

A comparison of sexual desire in opiate-dependent men receiving methadone and buprenorphine maintenance treatment
por: Yee, Anne, et al.
Publicado: (2019)

Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
por: Martin, Yvette N., et al.
Publicado: (2019)

Oxybutynin treatment for buprenorphine-naloxone-induced hyperhidrosis
por: McCormack, Lindsay, et al.
Publicado: (2021)

Disparities in Emergency Department Naloxone and Buprenorphine Initiation
por: Papp, Joan, et al.
Publicado: (2023)

Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
por: Kanervo, Minna M., et al.
Publicado: (2022)

Successful Management of Kratom Use Disorder With Buprenorphine and Naloxone
por: Arhin, Martin, et al.
Publicado: (2023)

A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
por: Simojoki, Kaarlo, et al.
Publicado: (2008)

Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone(®)) in Spain
por: Martinez-Raga, Jose, et al.
Publicado: (2012)

Utilizing buprenorphine–naloxone to treat illicit and prescription-opioid dependence
por: Mauger, Sofie, et al.
Publicado: (2014)

Low-dose naloxone provides an abuse-deterrent effect to buprenorphine
por: Webster, Lynn R, et al.
Publicado: (2015)

Neonatal outcomes following in utero exposure to buprenorphine/naloxone or methadone
por: Gawronski, Kristen M, et al.
Publicado: (2014)

Yoga as an Adjunctive Intervention to Medication-Assisted Treatment with Buprenorphine+Naloxone
por: Lander, Laura, et al.
Publicado: (2017)

Sexual dysfunction in men on buprenorphine – naloxone-based substitution therapy
por: Mattoo, Surendra K., et al.
Publicado: (2020)

Prenatal Buprenorphine/Naloxone or Methadone Use on Neonatal Outcomes in Michigan
por: Goshgarian, Gregory, et al.
Publicado: (2022)

Factors Associated With Sex-Related Pre-exposure Prophylaxis Adherence Among Men Who Have Sex With Men in New York City in HPTN 067
por: Mannheimer, Sharon, et al.
Publicado: (2019)

Short- and Long-Term Pharmacologic Measures of HIV Pre-exposure Prophylaxis Use Among High-Risk Men Who Have Sex With Men in HPTN 067/ADAPT
por: Velloza, Jennifer, et al.
Publicado: (2019)

No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Buprenorphine/Naloxone in Healthy Participants and Participants Receiving Stable Opioid Agonist Therapy
por: Feng, Hwa‐Ping, et al.
Publicado: (2018)

A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes
por: Lund, Ingunn O., et al.
Publicado: (2013)

Patient Satisfaction with Primary Care Office-Based Buprenorphine/Naloxone Treatment
por: Barry, Declan T., et al.
Publicado: (2007)

New developments in the management of opioid dependence: focus on sublingual buprenorphine–naloxone
por: Soyka, Michael
Publicado: (2015)

Evaluation of drug-drug interaction between daclatasvir and methadone or buprenorphine/naloxone
por: Garimella, Tushar, et al.
Publicado: (2014)

Safety and Efficacy of Buprenorphine-Naloxone in Pregnancy: A Systematic Review of the Literature
por: Ordean, Alice, et al.
Publicado: (2023)

Cross-Sectional Study of Risky Substance Use by Injured Emergency Department Patients
por: Strezsak, Valerie, et al.
Publicado: (2017)

Buprenorphine versus dihydrocodeine for opiate detoxification in primary care: a randomised controlled trial
por: Wright, Nat MJ, et al.
Publicado: (2007)

Use of HIV Case Surveillance System to Design and Evaluate Site-Randomized Interventions in an HIV Prevention Study: HPTN 065
por: Donnell, Deborah J, et al.
Publicado: (2012)

Comment on “A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence During Pregnancy: Maternal and Neonatal Outcomes”
por: Newman, Robert G., et al.
Publicado: (2013)

Outcomes among buprenorphine-naloxone primary care patients after Hurricane Sandy
por: Tofighi, Babak, et al.
Publicado: (2014)

Observational study of the safety of buprenorphine+naloxone in pregnancy in a rural and remote population
por: Jumah, Naana Afua, et al.
Publicado: (2016)

Buprenorphine/naloxone addiction in a pharmacist as a result of migraine self-treatment
por: Norton, Merrill, et al.
Publicado: (2016)

823 Evaluation of Drug-Drug Interaction between Asunaprevir and Methadone or Buprenorphine/Naloxone
por: Garimella, Tushar, et al.
Publicado: (2014)

Intravenous buprenorphine/naloxone and concomitant oral pregabalin misuse: a case report
por: Kulaksızoğlu, Burak, et al.
Publicado: (2018)

Validated Spectrophtometric Method for Simultaneous Determination of Buprenorphine and Naloxone in Pharmaceutical Dosage Forms
por: Souri, Effat, et al.
Publicado: (2017)

Therapy without a prescription: buprenorphine/naloxone diversion and the therapeutic assemblage in Taiwan
por: Chen, Jia‐shin
Publicado: (2019)

The use of buprenorphine/naloxone to treat borderline personality disorder: a case report
por: Hansen, Brenna, et al.
Publicado: (2022)

Successful Buprenorphine/Naloxone Low-dose Induction in Pregnancy: A Case Report
por: Coish, Rebecca, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_svkedlli286ujql6mv8ce6ec14